Astellas Pharma | 4503 - Ebit


Astellas Pharma reported JPY48.57B in EBIT for its fiscal quarter ending in March of 2026.





Ebit Change Date
Astellas Pharma JPY 48.57B 85.97B Mar/2026
Chugai Pharma JPY 160.86B 2.09B Jun/2026
Daiichi Sankyo JPY 85.1B 4.44B Jun/2026
Eisai JPY 24.73B 35.04B Jun/2026
Kyowa Hakko Kirin JPY 22.26B 12.74B Jun/2026
M3 JPY 10.65B 15.37B Mar/2026
Otsuka Holdings JPY 140.41B 22.2B Jun/2026
Shionogi JPY 66.91B 48.92B Jun/2026
Sumitomo Dainippon JPY 17.75B 21.31B Jun/2026
Takeda JPY 201.42B 215.04B Jun/2026
Terumo JPY 31.45B 12.43B Mar/2026